R I Shader - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R I Shader

Showing results (51-60 of 502) with videos related to

Pageof 51

Sort By:

The American Journal of Psychiatry|June 1, 1977

Clinical implications of benzodiazepine pharmacokineticsR I Shader, D J Greenblatt

Journal of Clinical Psychopharmacology|February 1, 1987

Bioequivalence of generic drugs in clinical psychopharmacologyD J Greenblatt, R I Shader

Journal of Clinical Psychopharmacology|March 1, 1981

Antidepressants: the second harvest and DSM-IIIR I Shader, D J Greenblatt

Lancet (London, England)|April 1, 1978

Prazepam, a precursor of desmethyldiazepamD J Greenblatt, R I Shader

Journal of Clinical Psychopharmacology|December 24, 1998

Potassium, antipsychotic agents, arrhythmias, and sudden deathR I Shader, D J Greenblatt

Journal of Clinical Psychopharmacology|August 1, 1995

Case 6: a free solutionR I Shader, J R Oesterheld

Journal of Clinical Psychopharmacology|October 1, 1996

Protease inhibitors and drug interactions--an alertR I Shader, D J Greenblatt

Journal of Clinical Psychopharmacology|February 1, 1990

Fluoxetine drug-drug interactions: I. Antidepressants and antipsychoticsD A Ciraulo, R I Shader

Southern Medical Journal|August 1, 1978

Pharmacokinetic understanding of antianxiety drug therapyD J Greenblatt, R I Shader

Journal of Clinical Psychopharmacology|June 1, 1985

The chronic patient: issues and concernsR I Shader, D J Greenblatt

Pageof 51

Search research articles

Showing results (51-60 of 502) with videos related to

Sort By:

Pageof 51

The American Journal of Psychiatry|June 1, 1977

Clinical implications of benzodiazepine pharmacokineticsR I Shader, D J Greenblatt

Journal of Clinical Psychopharmacology|February 1, 1987

Bioequivalence of generic drugs in clinical psychopharmacologyD J Greenblatt, R I Shader

Journal of Clinical Psychopharmacology|March 1, 1981

Antidepressants: the second harvest and DSM-IIIR I Shader, D J Greenblatt

Lancet (London, England)|April 1, 1978

Prazepam, a precursor of desmethyldiazepamD J Greenblatt, R I Shader

Journal of Clinical Psychopharmacology|December 24, 1998

Potassium, antipsychotic agents, arrhythmias, and sudden deathR I Shader, D J Greenblatt

Journal of Clinical Psychopharmacology|August 1, 1995

Case 6: a free solutionR I Shader, J R Oesterheld

Journal of Clinical Psychopharmacology|October 1, 1996

Protease inhibitors and drug interactions--an alertR I Shader, D J Greenblatt

Journal of Clinical Psychopharmacology|February 1, 1990

Fluoxetine drug-drug interactions: I. Antidepressants and antipsychoticsD A Ciraulo, R I Shader

Southern Medical Journal|August 1, 1978

Pharmacokinetic understanding of antianxiety drug therapyD J Greenblatt, R I Shader

Journal of Clinical Psychopharmacology|June 1, 1985

The chronic patient: issues and concernsR I Shader, D J Greenblatt

Pageof 51